Erythema multiforme

American Family Physician

Volumn 74, Issue 11, 2006, Pages 1883-1888

  Lamoreux, Michele R ^a   Sternbach, Marna R ^a   Hsu, W Teresa ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADALIMUMAB; AMFEBUTAMONE; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; CANDESARTAN HEXETIL; CIPROFLOXACIN; CYCLOSPORIN; CYCLOSPORIN A; DAPSONE; DIPHTHERIA TETANUS VACCINE; FAMCICLOVIR; HEPATITIS B VACCINE; HYDANTOIN DERIVATIVE; HYDROXYCHLOROQUINE; MEPACRINE; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENOTHIAZINE DERIVATIVE; PREDNISONE; ROFECOXIB; SMALLPOX VACCINE; SULFONAMIDE; THALIDOMIDE; VALACICLOVIR;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; ERYTHEMA MULTIFORME; HERPES SIMPLEX; HUMAN; HYPERSENSITIVITY REACTION; LABORATORY TEST; SKIN BIOPSY; SKIN DISCOLORATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; VIRUS INFECTION;

ACYCLOVIR; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; ERYTHEMA MULTIFORME; HUMANS;

EID: 33845351929     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ayangco L, Rogers RS III. Oral manifestations of erythema multiforme. Dermatol Clin 2003;21:195-205.
2. Volcheck GW. Clinical evaluation and management of drug hypersensitivity. Immunol Allergy Clin North Am 2004;24:357-71.
3. Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 2003;9:1.
4. Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am 2005;49:67-76.
5. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-6.
6. Habif TP. Hypersensitivity syndromes and vasculitis. In: Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. New York, N.Y.: Mosby, 2004:626-34.
7. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC, for the SCAR Study Group. Severe cutaneous adverse reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002;138:1019-24.
8. Shin HT, Chang MW. Drug eruptions in children. Curr Probl Pediatr 2001;31:207-34.
9. Leaute-Labreze C, Lamireau T, Chawki D, Maleville J, Taieb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000;83:347-52.
10. Huff JC. Erythema multiforme and latent herpes simplex infection. Semin Dermatol 1992;11:207-10.
11. Lam NS, Yang YH, Wang LC, Lin YT, Chiang BL. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. J Microbiol Immunol Infect 2004;37:366-70.
12. Villiger RM, von Vigier RO, Ramelli GP, Hassink RI, Bianchetti MG. Precipitants in 42 cases of erythema multiforme. Eur J Pediatr 1999;158:929-32.
13. Frederiksen MS, Brenoe E, Trier J. Erythema multiforme minor following vaccination with paediatric vaccines. Scand J Infect Dis 2004;36:154-5.
14. Loche F, Schwarze HP, Thedenat B, Carriere M, Bazex J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol 2000;25:167-8.
15. Cono J, Casey CG, Bell DM, for the Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR Recomm Rep 2003;52(RR-4):1-28.
16. Prais D, Grisuru-Soen G, Barzilai A, Amir J. Varicella zoster virus infection associated with erythema multiforme in children. Infection 2001;29:37-9.
17. Dumas V, Thieulent N, Souillet AL, Jullien D, Faure M, Claudy A. Recurrent erythema multiforme and chronic hepatitis C: efficacy of interferon alpha. Br J Dermatol 2000;142:1248-9.
18. Seishima M, Oyama Z, Yamamura M. Erythema multiforme associated with cytomegalovirus infection in nonimmunosuppressed patients. Dermatology 2001;203:299-302.
19. Ng PP, Sun YJ, Tan HH, Tan SH. Detection of herpes simplex virus genomic DNA in various subsets of erythema multiforme by polymerase chain reaction. Dermatology 2003;207:349-53.
20. Schechner AJ, Pinson AG. Acute human immunodeficiency virus infection presenting with erythema multiforme. Am J Emerg Med 2004;22:330-1.
21. Ejaz AA, Walsh JS, Wasiluk A. Erythema multiforme associated with candesartan cilexetil. South Med J 2004;97:614-5.
22. Sarkar R, Kaur C, Kanwar AJ. Erythema multiforme due to rofecoxib. Dermatology 2002;204:304-5.
23. Burger DE, Goyal S. Erythema multiforme from metformin. Ann Pharmacother 2004;38:1537.
24. Beuthien W, Mellinghoff HU, von Kempis J. Skin reaction to adalimumab. Arthritis Rheum 2004;50:1690-2.
25. Lineberry TW, Peters GE Jr, Bostwick JM. Bupropion-induced erythema multiforme. Mayo Clin Proc 2001;76:664-6.
26. Hallgren J, Tengvall-Linder M, Persson M, Wahlgren CF. Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug. J Am Acad Dermatol 2003;49(5 suppl):S267-9.
27. Sun Y, Chan RK, Tan SH, Ng PP. Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiforme by nested PCR. J Med Virol 2003;71:423-8.
28. Xu F, Schillinger JA, Sternberg MR, Johnson RE, Lee FK, Nahmias AJ, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002;185:1019-24.
29. Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993;128:542-5.
30. Kokuba H, Aurelian L, Burnett J. Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions. J Invest Dermatol 1999;113:808-15.
31. Erythema and urticaria. In: Odom RB, James WD, Berger TG, eds. Andrews' Diseases of the Skin: Clinical Dermatology. 9th ed. Philadelphia, Pa.: Saunders, 2000:146-51.
32. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York, N.Y.: McGraw-Hill, 2003:585-96.
33. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983;8:763-75.
34. Lemak MA, Duvic M, Bean SF. Oral acyclovir for the prevention of herpes-associated erythema multiforme. J Am Acad Dermatol 1986;15:50-4.
35. Tatnall FM, Schofield JK, Leigh IM. A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 1995;132:267-70.
36. Kerob D, Assier-Bonnet H, Esnault-Gelly P, Blanc F, Saiag P. Recurrent erythema multiforme unresponsive to acyclovir prophylaxis and responsive to valacyclovir continuous therapy. Arch Dermatol 1998;134:876-7.
37. Bakis S, Zagarella S. Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme. Australas J Dermatol 2005;46:18-20.
38. Conejo-Mir JS, del Canto S, Munoz MA, Rodriguez-Freire L, Serrano A, Hernandez C, et al. Thalidomide as elective treatment in persistent erythema multiforme; report of two cases. J Drugs Dermatol 2003;2:40-4.